The other adverse events issues questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device in an off-label location was ruled out as potential root cause.The clinical representative confirmed the patient does not have any contraindicating conditions, the neurostimulator was not implanted too close to the targeted nerve, and the needle did not inadvertently puncture bone or tissue during the procedure.It is unknown if the lead migrated.After reprogramming the transmitter, the patient improved and is no longer experiencing the burning and shocking.The stimulator is used to treat pain.The cause of the burning and shocking at the receiver pocket site is due to programming parameters as reprogramming the transmitter assembly resolved the reported issue (user error-clinical representative).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.
|